A less-than-ideal macroeconomic environment continued to inflict US venture funding into 2024 with Philadelphia’s dealmaking activity aligning with these broader trends. As investors flocked to safer bets, only select startups with defensible moats received checks, leading to greater capital consolidation as more capital was invested across fewer deals in 2024 than in 2023. Nonetheless, the region remains a key incubator of nascent tech and life sciences startups.
PACT’s latest report continues to assess key dealmaking trends and sector bright spots in the Philadelphia region and provides insights into:
- Why Philadelphia remains a robust facilitator of early-stage deal activity
- What a surge in exits means for Philadelphia’s dealmaking outlook
- How Philadelphia’s startup scene is rapidly leveraging AI to build lucrative and utilitarian business models